Fundz

Stalicla secures CHF 2 million funding led by Addex Therapeutics to advance precision medicine in neurodevelopmental disorders.

PRIVATEJun 30, 2025

Amount Raised

CHF2 Million

Round Type

Funding Round

GenevaBiotechnology

Investors

Addex Therapeutics

Description

Stalicla has closed a CHF 2 million financing round led by Addex Therapeutics. This funding will support operations and program development in neurodevelopmental disorders as Stalicla prepares for its upcoming Series C. Investor confidence in Stalicla’s innovative platform is highlighted by this financing, which also brings Tim Dyer onto the Board of Directors.

Quick answer

Stalicla raised CHF2 Million in a Funding Round round, dated June 30, 2025. Investors: Addex Therapeutics. Stalicla is based in Geneva, Geneva, Switzerland.

How much did Stalicla raise?
Stalicla raised CHF2 Million in a Funding Round round on June 30, 2025.
Who invested in Stalicla?
Addex Therapeutics is named as investors in this round.
What does Stalicla do?
STALICLA SA is a Swiss clinical-stage biopharmaceutical company, pioneering precision treatment in neurodevelopmental and neuropsychiatric disorders.
Where is Stalicla based and how big is it?
Stalicla is based in Geneva, Geneva, Switzerland. Fundz records about 26 employees.
Who are the decision-makers at Stalicla?
Fundz holds 1 contact at Stalicla. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Stalicla that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K on August 14, 2025.
  • Valthos raised $27M on August 14, 2025.
  • Ignitedata (Delaware) raised an undisclosed amount (Series A) on August 14, 2025.
  • Better Medicine raised $1.2M (Pre-Seed) on August 14, 2025.
  • Superluminal Medicines raised $5M on August 14, 2025.
  • X4 Pharmaceuticals raised $85M on August 13, 2025.

Who to call at Stalicla, and when

A new round usually means Stalicla is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Stalicla raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Stalicla, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Stalicla. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Stalicla

Location

Geneva, Geneva, Switzerland

About

STALICLA SA is a Swiss clinical-stage biopharmaceutical company, pioneering precision treatment in neurodevelopmental and neuropsychiatric disorders. With an advanced clinical pipeline of phase 2 and 3 ready assets and an AI-driven precision neuro medicine platform for patient-drug matching, STALICLA is changing the landscape of brain disease treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Stalicla raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Stalicla's next move

See what Strategic adds

Stalicla raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.